# A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

> **NCT00791258** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 999 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** amlodipine and olmesartan medoxomil tablets
- **DRUG:** hydrochlorothiazide tablets

## Key facts

- **NCT ID:** NCT00791258
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 999 (ACTUAL)
- **Last updated:** 2019-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791258, "A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00791258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*